TRENDS

• Chugai Aims to Surpass 200 Billion Yen in Its Domestic Oncology Sales in 2015
  February 13, 2015

• EFPIA Predicts Growth in Ethical Drug Market to Just 10 Trillion Yen in 2025
  February 6, 2015

• Edoxaban Approved in US with Restriction on Use; Impact on Daiichi Sankyo’s Midterm Business Plan Remains Unclear
  January 30, 2015

• Pneumococcal Vaccine Market Expanding with Inclusion in Publicly-Funded Vaccination Programs
  January 16, 2015

• Drug Makers Continue Trial and Error Efforts to Improve Lecture Meetings
  January 9, 2015

• ARBs at a Turning Point: Inroads by Generics to Lead to Gradual Decline in Sales
  December 26, 2014

• Pharmacist Society Criticizes Inappropriate Phrases in Materials Used by Sales Reps, Questions Use of Misleading Terms
  December 19, 2014

• Sales of Biosimilar EPO, G-CSF Growing as Awareness Increases
  December 12, 2014

• Industry Insiders, Healthcare Providers Call for Greater Focus on PMS by MRs, Criticize Excessive Focus on Product Promotion
  December 5, 2014

• Chugai’s Alecensa Off to a Good Start with Sales of 200 Million Yen in 1st Month
  November 28, 2014

• Bayer Sets Target of 30% Growth in Group Sales in Japan within 4 Years; Success to Depend Largely on 2 Core Products
  November 21, 2014

• Sales of Most Long-Listed Drugs Fall Short of Forecasts in Apr.-Sept.; Over 70% See Downward Revisions in Full-year Forecasts
  November 11, 2014

• Chugai Led in Research Grants Payment in FY2013; Grants Fell Among Major Drug Makers
  November 5, 2014

• Will Blopress AG Face Price War After Other Generics Debut in December?
  November 5, 2014

• Topical Combination Psoriasis Treatment Dovobet Debuts; Expected to Improve Patient QOL, Medication Adherence
  October 31, 2014

• Changes in Business Environment Spur Drug Makers to Reform Their Marketing Systems, Adopt Area Marketing Systems
  October 22, 2014

• LEP Agents Contributing to Expansion of Oral Contraceptives Market, Growing Use of Low-Dose Pill
  October 10, 2014

• Facing Unprecedented Patent Cliff for Abilify, Otsuka Holdings Sets Forth Plan to Achieve Recovery in 2018
  September 24, 2014

• Number of Females MRs Breaks 9,000 Mark with 1 in 3 in Their 20s, but Number in Management Positions Remains Low
  September 19, 2014

• With Entry of SGLT-2 Inhibitors, Competition Heating Up Again in Oral Anti-Diabetes Drug Market
  September 12, 2014

ページ